Trial Profile

An open label investigation of the tolerability and pharmacokinetics of oral cysteamine in adults with Cystic Fibrosis.

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 06 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Mercaptamine (Primary)
Indications Cystic fibrosis
Focus First in man; Pharmacokinetics

Most Recent Events

06 Apr 2017 This trial has been discontinued in UK (End date:2015-03-06) as per European Clinical Trials Database record.
24 Jun 2016 According to a NovaBiotics media release, data this trial was presented at the ASM Microbe conference.
14 Jun 2015 Status changed from recruiting to completed as reported by United Kingdom Clinical Research Network record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com